Diabetes

Rx for Change: Polycystic Ovary Syndrome (PCOS)

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | May 23, 2019 | Comments Off on Rx for Change: Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is another name for “chronic oligoanovulation”—irregular or absent ovulation resulting in  irregular or absent menstruation. PCOS may be associated with ovaries that have multiple cysts; hyperandrogenism (increased DHEA and/or testosterone); excessive facial or body hair (hirsuitism); acne; and weight gain.

The Great Diabetes Epidemic

By NWHN Staff | Mar 27, 2015 | Comments Off on The Great Diabetes Epidemic

In the past few months, there have been two deaths from Ebola in the United States, and half a dozen patients with the disease have been transferred from West Africa to specialized U.S. facilities for treatment. Americans are panicking about a U.S. Ebola epidemic, which has evoked a loud call for public health action — and generated efforts focused on prevention and vaccine development.

Rx for Change: Diabetic Neuropathy

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Sep 1, 2014 | Comments Off on Rx for Change: Diabetic Neuropathy

Diabetics often experience neuropathy (nerve pain or dysfunction); some people with diabetic neuropathy (DN) may be unaware of it because symptoms can be subtle. DN symptoms range from numbness or tingling to severe pain that interferes with daily activities and keeps people up at night.

Friends Don’t Let Friends Take Avandia

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Sep 22, 2010 | Comments Off on Friends Don’t Let Friends Take Avandia

In mid-July, a Food and Drug Administration (FDA) advisory committee voted to keep the diabetes drug Avandia (rosiglitazone) on the market, while simultaneously acknowledging not only that the drug increases the risk of heart attacks, but also that there are many other, safer medications available — including Actos (pioglitazone), a close sibling of Avandia made by a competing manufacturer.